These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8248558)

  • 1. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
    Ono K; Masunaga S; Akuta K; Akaboshi M; Abe M
    Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ; Horsman MR; Siemann DW
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
    Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A; Vojnovic B; Johns H; Joiner MC; Martindale C; Fowler JF; Denekamp J
    Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle dose rate irradiation in combination with carbogen inhalation selectively and more markedly increases the responses of SCCVII tumors.
    Ono K; Masunaga S; Akuta K; Akaboshi M
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):81-5. PubMed ID: 8175449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ; Menke D; Brown JM
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.
    Siemann DW; Horsman MR; Chaplin DJ
    Radiother Oncol; 1994 May; 31(2):117-22. PubMed ID: 8066190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotoxicity on bone marrow after 89Sr therapy radiosensitized by nicotinamide and carbogen in mice.
    Zhang Y; Zheng X; Li T; Guo Y; Hang R; Lin J; Gu W
    Nucl Med Commun; 2004 Jul; 25(7):701-4. PubMed ID: 15208497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance.
    Haustermans K; van der Kogel AJ; Vanacker B; van der Schueren E
    Radiother Oncol; 1994 May; 31(2):123-8. PubMed ID: 8066191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.
    Rojas A; Hirst VK; Calvert AS; Johns H
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):357-65. PubMed ID: 8567336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.
    Kaanders JH; Pop LA; Marres HA; Liefers J; van den Hoogen FJ; van Daal WA; van der Kogel AJ
    Radiother Oncol; 1998 Aug; 48(2):115-22. PubMed ID: 9783882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A; Menke D; Dorie MJ; Brown JM
    Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
    Stüben G; Stuschke M; Knühmann K; Horsman MR; Sack H
    Radiother Oncol; 1998 Aug; 48(2):143-8. PubMed ID: 9783885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An attempt to enhance chemosensitivity of quiescent cell populations in solid tumors by combined treatment with nicotinamide and carbogen.
    Masunaga S; Ono K; Akaboshi M; Kawai K; Akuta K; Takagaki M; Suzuki M; Kinashi Y; Abe M
    J Cancer Res Clin Oncol; 1996; 122(9):533-40. PubMed ID: 8781567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
    Bernier J; Denekamp J; Rojas A; Minatel E; Horiot J; Hamers H; Antognoni P; Dahl O; Richaud P; van Glabbeke M; Piérart M
    Radiother Oncol; 2000 May; 55(2):111-9. PubMed ID: 10799722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice.
    Sun LQ; Coucke PA; Mirimanoff RO; Buchegger F
    Radiat Res; 2001 Jan; 155(1 Pt 1):26-31. PubMed ID: 11121212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
    Horsman MR; Nordsmark M; Khalil AA; Hill SA; Chaplin DJ; Siemann DW; Overgaard J
    Acta Oncol; 1994; 33(4):371-6. PubMed ID: 8018368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment.
    Fatigante L; Ducci F; Cartei F; Colosimo S; Marini C; Prediletto R; Danesi R; Laddaga M; Del Tacca M; Caciagli P
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):499-504. PubMed ID: 9112444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice.
    Khandelwal SR; Kavanagh BD; Lin PS; Truong QT; Lu J; Abraham DJ; Schmidt-Ullrich RK
    Br J Cancer; 1999 Feb; 79(5-6):814-20. PubMed ID: 10070874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.